Chemotherapy Precautions and Safety - Why, How and What to do (for Nurses) Momoko Ito | Default

www.vet-webinar.com uses cookies to offer you the best possible service. Read more

Basket
English
Deutsch
English
Español
Français

Detail

chemotherapy-precautions-and-safety-why-how-and-what-to-do-for-nurses-1.jpeg

Chemotherapy Precautions and Safety - Why, How and What to do (for Nurses)

Duration: 0:45 h
Speaker: Momoko Ito
from 1 US$ 46.20
(incl. tax)
Description

Cancer frequently affects our veterinary patients and in recent years chemotherapy has become more commonly utilised treatment. General practices are increasingly prescribing and administering chemotherapy drugs. Chemotherapy drugs are toxic to cells (cytotoxic) interfering with the normal cell life cycle which results in cell death. Cancer cells are targeted by these drugs however they are not specific for cancer cells and healthy tissue can be affected.

Chemotherapy drugs are also carcinogenic, mutagenic, teratogenic and abortifacient. It is important that these drugs are handled safely. Personnel handling of chemotherapeutic drugs have been found to have increased risks of infertility, early pregnancy loss or urinary excretion of these drugs. This webinar will discuss the safety precautions necessary for handling chemotherapy agents and will focus on the recent consensus guidelines produced by the American College of Veterinary Internal Medicine (ACVIM) in January 2018 to raise awareness of risks and how we can reduce the exposure within clinics.

If time permits, common side effects (neutropaenia, thorombocytopaenia and gastrointestinal side effects) caused by chemotherapy will be explained as well as precautions for handling such patients.

Recording from 8 August 2019

BVSCMomokoIto_image.jpg
Momoko Ito

Momoko Ito. Veterinary Nurse (VTS, oncology)

Momoko is from Japan and moved to Brisbane in 2006. She completed a Bachelor of Veterinary Technology at the University of Queensland in 2011. She has worked in general practice before working at Brisbane Veterinary Specialist Centre. She started as a full-time rotating nurse at BVSC in 2011, then became BVSC's Primary Chemotherapy Nurse in 2013. Momoko also volunteered at the RSPCA Wildlife Hospital every Saturday for one year as well as taking casual shits at the BVECCS Emergency Centre.
In June 2018, Momoko passed the exam to become a Veterinary Technician Specialist (VTS) in Oncology accredited by the Academy of Internal Medicine Veterinary Technicians in the US. She is currently the first and the only VTS (Oncology) in Australia. Her daily goal is to give our patients the best attentions and care, and also to be the better communication bridge between owners and veterinarians to achieve a good quality of life in cancer patients. Her interest is not only limited to Oncology but also Internal Medicine and Feline Behaviour and Handling.
Momoko grew up with 4-6 cats. She admits being a crazy cat lady who also loves dogs. She enjoys yoga, indoor soccer and occasional hiking.

Back

You might also be interested in

staging-the-oncology-patient.png

Staging the Oncology Patient
Staging is one of the most important components of oncology case management. It involves determining the extent of local disease along with the presence or absence of regional or distant metastasis. The results of staging are used to give more accurate and informed treatment options along with prognostic information for each oncology patient. Some of the biggest challenges in staging is to consider how much staging is required for each case, which are the most appropriate tests, and if the results of these tests will impact treatment options and prognosis. I will discuss this information in a case-based and evidence-based approach, focusing on some of the more common cancers including canine mast cell tumours, lymphoma, oral tumours and apocrine gland anal sac adenocarcinomas.
Details
Duration: 0:57 h
Speaker: Laura Brockley
paraneoplastic-syndrome-1.jpeg

Paraneoplastic Syndrome
Cancer can do anything..... Paraneoplastic syndrome are symptoms that occur at sites distant from a tumour or its metastasis. During this seminar, we will explore the categories of paraneoplastic syndromes and explain the mechanisms of those where it is elucidated. We will look at the comparative aspect of paraneoplastic syndrome in human medicine.
Details
Duration: 0:45 h
Speaker: Valerie J. Poirier
approach-to-canine-mast-cell-tumours-and-soft-tissue-sarcomas.jpeg

Approach to canine mast cell tumours and soft tissue sarcomas
Mast cell tumours (MCT) and soft tissue sarcomas (STS) are some of the most common tumours encountered in small animal practice. Although surgical removal is often the most appropriate initial treatment, questions like whether or not to perform staging tests prior to surgery, identification of cases where surgery may not be recommended, treatment options for non-surgical cases, interpretation of prognostic factors and the best approach for follow up can be more challenging. In this webinar we will discuss initial diagnosis of canine MCT and STS, when and which staging tests are appropriate for different cases, interpretation of histopathology reports and grading schemes, and non-surgical treatment options. We will discuss in more depth the use of receptor tyrosine kinase inhibitors such as Palladia in canine MCT.
Details
Duration: 1:03 h
Speaker: Claire Cannon